| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 63.641 | 283.835 | 255.244 | 339.876 | 483.203 | 497.977 | 712.188 |
| Total Income - EUR | - | - | - | 63.641 | 284.061 | 272.167 | 340.628 | 485.761 | 500.217 | 721.327 |
| Total Expenses - EUR | - | - | - | 17.842 | 156.141 | 155.393 | 172.564 | 300.514 | 356.950 | 950.019 |
| Gross Profit/Loss - EUR | - | - | - | 45.800 | 127.920 | 116.775 | 168.065 | 185.247 | 143.267 | -228.692 |
| Net Profit/Loss - EUR | - | - | - | 44.487 | 125.081 | 113.135 | 165.074 | 180.415 | 138.287 | -250.065 |
| Employees | - | - | - | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Neo Biotech World S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 47 | 0 | 0 | 17.872 | 19.761 | 34.245 | 48.224 |
| Current Assets | - | - | - | 127.211 | 223.264 | 300.292 | 524.617 | 724.976 | 912.159 | 523.415 |
| Inventories | - | - | - | 96.430 | 120.329 | 243.007 | 464.482 | 609.208 | 852.160 | 390.261 |
| Receivables | - | - | - | 8.077 | 60.788 | 44.384 | 48.278 | 83.375 | 52.242 | 61.418 |
| Cash | - | - | - | 22.704 | 42.147 | 12.901 | 11.857 | 32.393 | 7.757 | 71.736 |
| Shareholders Funds | - | - | - | 44.530 | 149.672 | 259.970 | 419.279 | 558.304 | 694.898 | 432.928 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 82.729 | 73.592 | 40.322 | 123.209 | 186.433 | 251.507 | 138.761 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Neo Biotech World S.r.l.